These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2403290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Variation between three strains of rat: inhibition of neurotoxic esterase and acetylcholinesterase by tri-o-cresyl phosphate.
    Carrington CD, Abou-Donia MB.
    J Toxicol Environ Health; 1988; 25(3):259-68. PubMed ID: 3184197
    [Abstract] [Full Text] [Related]

  • 4. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
    Chambers JP, Hartgraves SL, Murphy MR, Wayner MJ, Kumar N, Valdes JJ.
    Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
    [Abstract] [Full Text] [Related]

  • 5. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
    Yang ZP, Dettbarn WD.
    Biochem Pharmacol; 1998 May 01; 55(9):1419-26. PubMed ID: 10076534
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM, Brecht KM, O'Neill BL.
    Toxicol Lett; 1987 Nov 01; 39(1):35-42. PubMed ID: 3672554
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition kinetics of acetylcholinesterase and butyrylcholinesterase from various species by 2-(2-cresyl)-4H-1,3,2-benzodioxaphosphorin-2-oxide (CBDP).
    Horn G, Rappenglück S, Worek F.
    Toxicol Lett; 2024 May 15; 396():28-33. PubMed ID: 38642675
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP.
    Garrett TL, Rapp CM, Grubbs RD, Schlager JJ, Lucot JB.
    Neurotoxicology; 2010 Sep 15; 31(5):502-8. PubMed ID: 20510297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG, Benschop HP, DeJong LP, Wolthuis OL.
    Toxicol Appl Pharmacol; 1987 Jun 15; 89(1):141-3. PubMed ID: 3590185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
    Little JS, Maxwell DM, Fox-Talbot MK, Brecht K, Lenz DE.
    Biochem Pharmacol; 1990 Oct 15; 40(8):1733-7. PubMed ID: 2242010
    [Abstract] [Full Text] [Related]

  • 18. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
    Due AH, Trap HC, Van Der Wiel HJ, Benschop HP.
    Arch Toxicol; 1993 Oct 15; 67(10):706-11. PubMed ID: 8135661
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.